AgingResearch.NewsJoin free

Phase 2/3Terminated

Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis

Sponsor
Turku University Hospital (Government)
Enrolment
5 enrolled
Conditions
Pulmonary Sarcoidosis
Interventions
Methionine; DOTANOC
Ages
adults, older adults
Registry
NCT02824419

Full record on ClinicalTrials.gov

From the registry

The goal of the current study is to evaluate the potential of the selected PET tracers to detect sarcoidotic lesions in lungs. The tracers are already in clinical use for the detection of certain inflammatory processes or malignant tumors, and their targets present similarities with molecular mechanisms of sarcoidosis.

Primary outcomes

  • The detection of sarcoidotic lesion with C11-methionine or 68Ga-DOTANOC.

History

  1. Last registry update

  2. Study completion

  3. Primary completion

  4. Registered

  5. Started